#alzheimers
Related Stories (3)
NEWSLETTER: Genetic discovery yields clues toward reversal of Alzheimer's brain damage - Reuters
NEWSLETTER: Genetic discovery yields clues toward reversal of Alzheimer's brain damage Reuters
September 25, 2026Ex-Channel 4 News host Jon Snow reveals he has Alzheimer's
Snow, the lead presenter of C4 News for 32 years, will be seen navigating his diagnosis in a new film.
June 5, 2026US FDA approves Axsome's drug for Alzheimer's-related agitation - Reuters
US FDA approves Axsome's drug for Alzheimer's-related agitation Reuters
April 30, 2026Related Pages (5)
Jon Snow reveals he has been privately battling Alzheimer's for years as former Channel 4 news anchor announces diagnosis
News | UK Former Channel 4 News anchor Jon Snow has revealed he has been diagnosed with Alzheimer’s and has been privately battling the disease for years. The 78-year-old journalist will discuss the
Legendary TV newsreader Jon Snow reveals Alzheimer’s battle
Legendary newsreader Jon Snow has revealed that he is battling Alzheimer’s. Jon, who was Channel 4’s longest serving newsreader, has been privately battling the disease for years. In a new interview
News in brief
<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5ZV86V9" height="0" width="0" style="display:none;visibility:hidden"></iframe> BioWorld. Link to homepage.
US FDA approves Axsome’s drug for Alzheimer’s-related agitation
By Kamal Choudhury and Mariam Sunny April 30 (Reuters) – The U.S. Food and Drug Administration has approved Axsome Therapeutics’ drug to treat agitation in patients with Alzheimer’s disease, the com
Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
April 30, 2026 14:06 ET | Source: Axsome Therapeutics, Inc. Axsome Therap